Early Bird Ends Tomorrow

August 5, 2021 ~ Next Phase Admin ~ Leave a comment

By Caitlin Dolegowski, Marketing Specialist, LSN

RESI Partnering Week, September 13-17 early bird rates end tomorrow! Register by August 6 to save $50 on standard, premier, and bundle packages. RESI Partnering Week is a five-day virtual partnering experience designed to connect early-stage life science and healthcare startups with investors and strategic partners that are a fit for their product and stage of development.

RESI Partnering Week is unique because it features three events (Digital RESI, RESI AI, and RESI Longevity) that each use a match-based partnering platform designed to take the guesswork out of partnering because it enables users to filter attendees to meet with based on their fundraising needs. To learn more about the partnering platform, join us for a free fundraising bootcamp August 11 or August 18.

Additionally, RESI Partnering Week features conversations with entrepreneurs and investors around specific topics related to the early-stage fundraising ecosystem through expert panels and hosts the Innovator’s Pitch Challenge (IPC), providing opportunities for fundraising executives to pitch directly to a panel of relevant, active investors. IPC applications are accepted on a first-come-first-serve basis, so apply by August 20 to be considered!

Whether sourcing elite technology assets or seeking funding from a strategic partner who is a fit for your company, RESI Partnering Week is a one-stop shop to help you meet your needs. Learn more about what each event has to offer and sign up by August 6 to save!

RPW September 2021 Confirmed Investors
Confirmed RESI Investors	Confirmed RESI AI Investors	Confirmed RESI Longevity Investors

As of August 5

Tech Hubs & RESI Partnering Week

August 5, 2021September 24, 2021 ~ Next Phase Admin ~ Leave a comment

By Elizabeth Murphy, Manager of Business Development, LSN

Life Science Nation (LSN) recognizes how Tech Hubs – global incubators and accelerators – are impact entrepreneurs for success, and in turn, close collaboration with these groups and their constituent companies add a value to partnering events, like RESI Partnering Week. Over the last year, LSN has hosted Tech Hubs such as AZ Bio, Women in Bio, and Lyonbiopole and their constituents have had the opportunity to meet the investors and strategic partners who are part of the RESI community. Get to know these Tech Hubs and check out the opportunities available to constituents of those participating in the RESI Partnering Week Global Tech Hub Gathering:

We are currently offering two programs to accelerate Tech Hub involvement and help fund constituents:

50% discount on any RESI conference registration for early-stage constituent companies from participating Tech Hubs
Group Fundraising Package ($1,500 per company) for Tech Hubs including:
3-month access to the Investor Database
Registration at RESI
Participation in the Innovator’s Pitch Challenge

The Arizona Bioindustry Association (AZBio)

AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona’s life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed. AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations. Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and MedTech community.

Lyonbiopole

As a Cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne-Rhône-Alpes region. It’s supporting ambitious projects and innovative companies in the healthcare and life sciences sectors. Its aim is to help innovators develop new technologies, products, and services in a push toward a more personalized medicine and better treatments for patients. Its four strategic areas include human medicine, veterinary medicine, in vitro diagnostics, and medical devices and medical technologies.

Women in Bio (WIB)

Women in Bio is an incubator of North American women in the life science industry. WIB aims to help women achieve the highest levels of leadership, influence and decision-making that they desire. As WIB grows its membership, its activities, and its geographic spread, it is rapidly becoming a leading authority and organization for women in the life sciences. Their focuses are on education, mentoring and networking, and on creating opportunities for leadership that can help advance careers. In the past WIB has been an incredible addition to the RESI conferences, sending esteemed life science women entrepreneurs to connect with investors specific to their indication. We look forward to working with them back again at future RESI conferences.

If your Tech Hub is looking for ways to add value to fundraising constituents, connect with the LSN business development team to see which offerings best fit your needs and the companies in your community. LSN shares the mission of global Tech Hubs in seeing promising technologies advance from the lab to the clinic, and into the hands of providers and their patients.

Want to learn more? The business development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International & MA (USA)	West Coast (USA)	East Coast (USA)	Midwest (USA) & Canada

Greg Mannix Vice President International Business Development Book a Meeting!	Candice He Global Investment Strategist Book a Meeting!	Elizabeth Murphy Manager of Business Development Book a Meeting!	Antoinette Lowre Manager of Business Development Book a Meeting!

Hot Longevity Mandates: Multinational Venture Firm

August 3, 2021 ~ Next Phase Admin ~ Leave a comment

The firm is a venture capital fund founded in 1996 with offices in the US, China, and Japan. The firm has over $4.2B assets under management and has invested in over 400 companies. In 2019, the firm closed Fund IX at $780M, its largest fund to date. The firm invests mainly in early-stage technology companies (i.e. internet, SaaS, consumer-tech, etc.) with high disruptive potential and seeks to be the first institutional investor, but dedicates a small amount of capital (about 20% of the fund) to later-stage companies as well. Typically, first checks fall in the $2-5M range in Seed to Series A rounds, but the firm has made investments as small as $250K. Overall, the firm invests in over 20 companies per year across North America and Asia. In terms of healthtech specifically, the firm aims to make at least 1-2 USA-based and 1 China-based investments per year.

The firm is mainly interested in digital health opportunities and will not consider therapeutics or medical devices. The firm will stray away from anything that involves FDA regulatory approval. Previous investments of the firm include a Google Glass-powered remote scribe platform that improves the workflow of physicians, an AI engine that matches cancer patients with clinical trials, a wearable health tracker for healthy lifestyle management, etc. Companies do not need to be generating revenue prior to investment.

The firm invests in private companies with strong technology and can work with different kinds of management teams that are ideally devoted full-time to the company. The firm will almost always act as the lead investor and seek board representation, staying actively involved in their portfolio companies. The firm prefers to have a syndicate of co-investors invest alongside the firm, but this is not an absolute requirement.

If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.

Improving Diabetes Management with AI-Driven Glucose Sensors – Interview with Marc Ripper, PhD, CEO of Alertgy

August 2, 2021June 15, 2022 ~ Next Phase Admin ~ Leave a comment

By Erika Wu, Business Development Representative, LSN

Is the future of diabetes management here? Learn about what Dr. Marc Rippen and his team at Alertgy are achieving with their patented technology and artificial intelligence (AI) to provide on-demand blood glucose readings. You can also see Alertgy at the Innovator’s Pitch Challenge during the digital RESI Partnering Week, September 13-17. Join RESI AI (September 16-17) for dynamic panels, as well as opportunities to pitch to a live panel of investors. Learn more about how you can get involved and tell your story at Innovator’s Pitch Challenge!

Investment Opportunities Abound at RESI Partnering Week

July 29, 2021 ~ Next Phase Admin ~ Leave a comment

By Karen Deyo, Director of Investor Research, Israel BD, LSN

The summer flying by means one thing: RESI Partnering Week is on its way, and with it comes an avalanche of opportunities to meet with the many investors already signed up! The virtual RESI events have been met with growing interest from early-stage investors, as it provides them with opportunities to invest globally despite the travel restrictions. CB Insights recently reported that investments, both in numbers and investment dollars, have both risen steadily in the past year, indicating that there are plenty of funds out there for fundraising CEOs to tap into.

Check out the latest list of investors attending RESI Partnering Week, including Digital RESI September, RESI AI, and RESI Longevity, September 13-17, and take advantage of the early bird rate ending next week.

RPW Sept. 2021 Confirmed Investors
Confirmed RESI Investors	Confirmed RESI AI Investors	Confirmed RESI Longevity Investors

As of July 29

Financing Scientific Instrumentation as a Start-Up Company

July 29, 2021 ~ Next Phase Admin ~ Leave a comment

By Antoinette Lowre, Manager of Business Development, LSN

Over the last several years, a record number of exciting life sciences start-ups have come online. Most of these start-up companies need scientific instrumentation to support their research. But when funds are limited, how can these companies get the instrumentation needed to hit their growth milestones?

Bold View Capital is hosting a workshop as part of the Service Provider Showcase at Digital RESI, September 13-16. The workshop will kick-off with an overview of the leasing market for start-ups. Expert panel will share their own experiences going through the leasing process and offer valuable lessons learned.

This workshop is valuable for start-up companies:

That rely on scientific instrumentation
That are pre-revenue and have limited funds to purchase instrumentation
For whom traditional financing is not available
That prefer debt financing to diluting equity

Instructors:

Darren Platt, President, Demetrix
Bryan Leavitt, Managing Partner, Fountainhead Investment Partners
Chad Kobold, Director of Business, Development, Bold View Capital

Join Bold View Capital on Wednesday, September 15 at 1 PM EDT. Sign up by August 6 to save on early bird rates!

Does it Work?

July 29, 2021July 29, 2021 ~ Next Phase Admin ~ Leave a comment

By Rory McCann, Marketing Manager & Conference Producer, LSN

I’ve heard a lot about RESI through the years, but does it work?

The question that comes from every fundraising executive at some point takes many forms, but this is frequently the hardest to answer. To do so requires a basic understanding of the Fundamental Facts of Fundraising, before explaining what RESI will and won’t do. While many entrepreneurs would enthusiastically jump at the promise of a partnering conference series offering low effort and high yield in terms of booking meetings with qualified investors and walking out with a term sheet or more, but reality doesn’t align with that story. Instead, reality aligns with the truths outlined below:

Fundamental Facts of Fundraising:

Funding a startup into early-stage success and beyond is incredibly difficult and RESI won’t change that.
Fundraising is a numbers game.
Your best chances come from a good fit based on product and stage of development.
There are strategies and best practices that set you up for success.
You get out what you put in.

While not a silver bullet to any of the above, instead, RESI is a powerful tool that is:

Designed to help early-stage entrepreneurs in life science and healthcare. That’s it. Every product, service, and resource are geared towards setting up scientific startups for success.
A model that takes place five times each year with thirteen conferences, bringing in hundreds of investors and early-stage companies each time, creating many opportunities to book meetings.
A connection vehicle that is designed for attendees to seek and target the best fits for their needs through its match-based partnering system.
Equipped with an arsenal of resources set up for the early-stage entrepreneur to be successful in sourcing and booking well-fitting meetings, including free fundraising bootcamps, database subscriptions, branding and messaging services, one-day prep courses, and countless articles outlining best practices, marketing collateral, outreach strategies, and a four-step follow-up process.
Rewarding to those who apply proven strategies and are willing to work.

No matter how expensive or high quality, a hammer will only build a house in the hands of a builder who knows how to use it and shows up to work. I recently connected with two CEOs – one had a very negative perspective of his RESI experience and one with a very positive one.

The first CEO stated that RESI was the “world’s worst meeting ever” and insinuated that he was more deserving of investors’ time with “hit my name in Google”. When I dug deeper, it was clear that he had sent roughly 15% of the meeting invitations of his counterparts with no attempt at follow-up. I’m not surprised he did not have a better experience.

The second CEO shared that he had had a very positive experience at RESI. He then outlined his pre-conference strategy in which he identified several investors who were an excellent fit for his company, and even prepared a secondary list of investors who were less of a match, but still may consider taking a meeting – which he inevitably used when an investor was unable to connect. He also detailed his post-conference follow-up strategy. He shared how he recognized the opportunity available to him and he was willing to work hard to make the most of it. While he didn’t ask me to “hit his name in Google”, I did anyway. His company raised a multi-million-dollar Series A shortly afterwards. Unsurprisingly, it says more about his ethic than whether a partnering conference “works”.

Like most things worth our time and effort, RESI is a valuable tool that will work if you do. Join us September 13-17 to see what it’s all about at the virtual RESI Partnering Week. Save when you register by August 6. We hope to see you virtually there!